Form 4: Oscar Health CLO Sells Shares for Tax Obligations

Oscar Health's Chief Legal Officer, Adam McAnaney, reported the acquisition of restricted stock units and the sale of shares to cover tax withholding obligations.

Summary

• Adam McAnaney, Chief Legal Officer of Oscar Health, Inc., reported transactions on March 2, 2026.
• Acquired 67,424 shares of Class A Common Stock at a price of $0, representing restricted stock units that will vest quarterly in 12 equal installments beginning on June 1, 2026, subject to continuous service.
• Sold 18,710 shares of Class A Common Stock at a weighted average price of $13.39 per share, with individual transactions ranging from $13.00 to $13.85.
• The sale was executed pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025, specifically to satisfy tax withholding obligations upon the vesting of previously granted equity awards.
• Following these transactions, McAnaney beneficially owns 227,955 shares of Class A Common Stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event. The RSU grant aligns executive interests, and the sale for tax purposes is a routine, pre-planned event, not indicative of a negative outlook on the company.

Positives

• The acquisition of 67,424 restricted stock units indicates continued equity compensation for a key executive, aligning management's interests with shareholders' long-term value creation.

Negatives

• The sale of 18,710 shares by a Chief Legal Officer, even for tax purposes, represents a reduction in direct insider ownership.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those executed under Rule 10b5-1 plans for tax purposes, are common occurrences in the executive compensation landscape across various industries. While the sale reduces direct insider holdings, the pre-planned nature mitigates concerns about discretionary selling based on non-public information.

Comparison to Industry Standards

• Form 4 filings detailing RSU grants and subsequent sales for tax withholding are standard practice for executives in publicly traded companies, including those in the health insurance technology sector like Oscar Health.
• This aligns with typical executive compensation structures seen at peers such as Clover Health (CLOV) or Bright Health Group (BHG), where equity awards are a significant component of remuneration, often leading to similar tax-related sales upon vesting.

Related Party Transactions

• The transactions involve the Chief Legal Officer and the company's equity, which are standard related party dealings in the context of executive compensation.

Stakeholder Impact

• Shareholders: The grant of restricted stock units aligns the Chief Legal Officer's interests with long-term shareholder value. The sale for tax purposes is a routine event and has minimal impact on overall share structure.
• Employees: Reflects standard executive compensation practices, potentially setting a precedent for other equity award recipients.

Next Steps

• The acquired restricted stock units will begin vesting quarterly in 12 equal installments starting June 1, 2026.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions related to executive compensation and tax obligations. The acquisition of restricted stock units aligns management incentives, while the sale for tax purposes is a common, pre-planned event under a Rule 10b5-1 plan. These transactions do not provide new fundamental information about Oscar Health's operational performance or strategic direction that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate, maintaining current positions while awaiting more substantive corporate updates.

Keywords

Oscar Health, OSCR, Form 4, Insider Transaction, Adam McAnaney, Chief Legal Officer, Restricted Stock Units, Equity Compensation, Rule 10b5-1, Tax Withholding